Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H J Heidebrecht

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Genomics|September 21, 2000
Cloning and localization of C2orf2(ropp120), a previously unknown WD repeat proteinH J Heidebrecht, F Buck, M Pollmann, et al.
The American Journal of Pathology|August 1, 1997
Sinus-lining cells of the lymph nodes recognized as a dendritic cell type by the new monoclonal antibody Ki-M9H H Wacker, S O Frahm, H J Heidebrecht, et al.
Cell Proliferation|July 1, 1996
Monoclonal antibodies Ki-S3 and Ki-S5 yield new data on the 'Ki-67' proteinsH J Heidebrecht, F Buck, K Haas, et al.
Verhandlungen Der Deutschen Gesellschaft Fur Pathologie|January 1, 1992
[Sinus lining cells:morphology, function and neoplasia]H H Wacker, H J Heidebrecht, H J Radzun, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 10, 1998
The immunohistochemical marker Ki-S2: cell cycle kinetics and tissue distribution of a novel proliferation-specific antigenP Rudolph, R Knüchel, E Endl, et al.
Blood|July 1, 1997
p100: a novel proliferation-associated nuclear protein specifically restricted to cell cycle phases S, G2, and MH J Heidebrecht, F Buck, J Steinmann, et al.
Human Pathology|March 29, 2001
Concurrent overexpression of p53 and c-erbB-2 correlates with accelerated cycling and concomitant poor prognosis in node-negative breast cancerP Rudolph, P Alm, H Olsson, et al.
The American Journal of Pathology|June 1, 1993
Determination of the growth fraction in non-Hodgkin's lymphomas by monoclonal antibody Ki-S5 directed against a formalin-resistant epitope of the Ki-67 antigenH Kreipe, H H Wacker, H J Heidebrecht, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1994
Secondary combined resistance to the multidrug-resistance-reversing activity of cyclosporin A in the cell line F4-6RADR-CsAM Dietel, I Herzig, A Reymann, et al.
Journal of the National Cancer Institute|February 26, 1999
Immunologic proliferation marker Ki-S2 as prognostic indicator for lymph node-negative breast cancerP Rudolph, P Alm, H J Heidebrecht, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Genomics|September 21, 2000
Cloning and localization of C2orf2(ropp120), a previously unknown WD repeat proteinH J Heidebrecht, F Buck, M Pollmann, et al.
The American Journal of Pathology|August 1, 1997
Sinus-lining cells of the lymph nodes recognized as a dendritic cell type by the new monoclonal antibody Ki-M9H H Wacker, S O Frahm, H J Heidebrecht, et al.
Cell Proliferation|July 1, 1996
Monoclonal antibodies Ki-S3 and Ki-S5 yield new data on the 'Ki-67' proteinsH J Heidebrecht, F Buck, K Haas, et al.
Verhandlungen Der Deutschen Gesellschaft Fur Pathologie|January 1, 1992
[Sinus lining cells:morphology, function and neoplasia]H H Wacker, H J Heidebrecht, H J Radzun, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 10, 1998
The immunohistochemical marker Ki-S2: cell cycle kinetics and tissue distribution of a novel proliferation-specific antigenP Rudolph, R Knüchel, E Endl, et al.
Blood|July 1, 1997
p100: a novel proliferation-associated nuclear protein specifically restricted to cell cycle phases S, G2, and MH J Heidebrecht, F Buck, J Steinmann, et al.
Human Pathology|March 29, 2001
Concurrent overexpression of p53 and c-erbB-2 correlates with accelerated cycling and concomitant poor prognosis in node-negative breast cancerP Rudolph, P Alm, H Olsson, et al.
The American Journal of Pathology|June 1, 1993
Determination of the growth fraction in non-Hodgkin's lymphomas by monoclonal antibody Ki-S5 directed against a formalin-resistant epitope of the Ki-67 antigenH Kreipe, H H Wacker, H J Heidebrecht, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1994
Secondary combined resistance to the multidrug-resistance-reversing activity of cyclosporin A in the cell line F4-6RADR-CsAM Dietel, I Herzig, A Reymann, et al.
Journal of the National Cancer Institute|February 26, 1999
Immunologic proliferation marker Ki-S2 as prognostic indicator for lymph node-negative breast cancerP Rudolph, P Alm, H J Heidebrecht, et al.
Pageof 2